Chewy Sinks 11% as Free Cash Flow Miss Overshadows Raised Outlook; Petco Falls 6%, Freshpet Ticks Up

Chewy (NYSE:CHWY | CHWY Price Prediction) stock is down 11% midday on Wednesday to $20.68 after the online pet retailer reported fiscal Q2 2027 results that carried a free cash flow shortfall large enough to swamp a raised full-year outlook. The setup is unusual because both the revenue and the adjusted earnings landed close to where analysts had expected.

The selling is spreading across pet-retail stocks. Petco Health and Wellness (NASDAQ:WOOF) stock is down 6% to $2.45, extending a rough stretch for the brick-and-mortar chain. Meanwhile, Freshpet (NASDAQ:FRPT) stock is moving slightly higher against sector weakness, up 0.41% to $67.55, as the premium fresh-food maker looks insulated from Chewy’s specific issues.

The broader market backdrop offers no cover either. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is down 0.4% in the same session, a modest pullback that highlights how idiosyncratic the pet retail move looks today.

Free Cash Flow Miss Overshadows Raised Guidance

Chewy’s adjusted diluted EPS of $0.36 came in line with the $0.3614 consensus, and revenue of $3.33 billion beat by 0.4% and grew 7.3% year over year. Management then raised the full-year outlook, guiding fiscal 2026 net sales to $13.46 billion to $13.57 billion and lifting the low end of adjusted EBITDA margin guidance by 10 basis points.

The problem sits on the cash line. Chewy’s free cash flow of $89.5 million declined 15.5% year over year, with capital expenditures surging 71.1% to $47.9 million as the company absorbs integration costs tied to SmartPak and the $400 million Modern Animal veterinary acquisition. CFO Chris Deppe told analysts the shortfall was “entirely timing-related,” and reiterated a full-year free cash flow conversion target of “roughly 80%.”

Analysts at Jefferies flagged one-time items and timing factors behind the profit result, noting that guidance implying stable core growth alongside heavy reinvestment makes the quarter weaker than the headline figures suggest. They characterized Chewy’s veterinary and equestrian buildout as sensible while calling the payoff timeline uncertain.

Sector Splits Between Retail and Fresh Food

The pet retail read-through hit Petco despite the company’s own recent Q2 that beat GAAP EPS estimates by 80.3% and posted a second straight quarter of positive comparable sales at 0.6%. Petco stock had already been down 12.5% year to date entering today, and the Chewy reaction is extending that pressure.

Freshpet is trading in the other direction. The company raised its 2026 net sales growth outlook to 10% to 12% back in August, delivered 15.5% revenue growth, and lifted its 2027 adjusted gross margin target above 49%. CEO Billy Cyr told analysts that “fresh is the future of pet food,” and shareholders appear willing to separate that story from Chewy’s cash reinvestment cycle.

The ProShares Pet Care ETF (CBOE:PAWZ) captures both sides of the divergence, since Chewy and Freshpet each sit near 9.9% and 9.8% of the fund’s net assets while Petco represents a smaller 2.65% position. The fund had already been down 7.1% year to date entering into today’s session.

What to Watch Next

The recurring-revenue argument is where the bull case sits. Autoship customer sales made up 84.6% of Chewy’s total net sales in the quarter, up from 83% a year ago, and active customers grew 3.8% to 21.705 million. That subscription base keeps buying regardless of the quarter, which is why some analysts view the reinvestment cycle as a cost that arrives now against benefits that arrive later.

Investors may want to check for whether Chewy management’s upcoming Goldman Sachs consumer conference commentary clarifies the cadence of free cash flow recovery. Position sizing on Chewy stock should reflect that the payoff on veterinary and equestrian expansion remains a multi-quarter question rather than a next-quarter catalyst; today’s session suggests that the market is willing to punish that timing gap even when the top line and the outlook seem favorable.

Contact [email protected] for any questions or corrections.